Complete Filing Data
TELA Bio, Inc. reported Stockholders Equity of $6.31 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TELA Bio, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$38.8M | -$37.8M | -$46.7M | -$44.3M | -$33.3M | -$28.8M | -$22.4M | -$21.1M | -$21.3M |
| Selling And Marketing Expense | $63.2M | $64.6M | $59.7M | $43.3M | $29.1M | $22.1M | $18.1M | $13.6M | $8.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $80.3M | $69.3M | $58.5M | $41.4M | $29.5M | $18.2M | $15.4M | $8.3M | $4.2M |
| Research And Development Expense | $9.2M | $8.8M | $9.6M | $8.9M | $6.7M | $4.3M | $4.2M | $4.3M | $5.8M |
| Other Nonoperating Income Expense | $1.3M | $1.4M | $2.6M | -$10.0K | -$228.0K | $45.0K | $351.0K | $70.0K | -$4.4M |
| Operating Income Loss | -$33.8M | -$34.1M | -$44.1M | -$39.0M | -$29.5M | -$25.3M | -$19.2M | -$17.8M | -$16.9M |
| Operating Expenses | $88.1M | $88.2M | $84.2M | $66.1M | $48.3M | $36.5M | $28.4M | $20.7M | $19.5M |
| Gross Profit | $54.3M | $46.5M | $40.1M | $27.0M | $18.8M | $11.2M | $9.3M | $2.9M | $2.5M |
| General And Administrative Expense | $15.7M | $14.7M | $14.9M | $13.9M | $12.5M | $10.1M | $6.2M | $4.9M | $5.0M |
| Comprehensive Income Net Of Tax | -$38.8M | -$37.8M | -$46.7M | -$44.1M | -$33.3M | -$28.8M | -$22.4M | -$21.1M | -$21.3M |
| Cost Of Goods And Services Sold Amortization | $380.0K | $380.0K | $380.0K | $804.0K | $304.0K | $304.0K | $304.0K | $785.0K | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $1.0K | -$1.0K | -$59.0K | $202.0K | $19.0K | -$52.0K | -$15.0K | ||
| Nonoperating Income Expense | -$4.8M | -$3.9M | -$2.6M | -$5.3M | -$3.8M | -$3.5M | -$3.3M | -$3.3M | |
| Interest Expense | $5.2M | $4.1M | $3.6M | $3.6M | $3.6M | $1.8M | $4.6M | ||
| Interest Expense Nonoperating | $5.2M | $5.3M | $5.2M | $4.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$8.6M | -$9.9M | -$11.3M | -$10.4M | -$12.6M | -$5.7M | -$11.0M | -$10.8M | -$12.0M | -$10.7M | -$12.7M | -$10.9M | -$8.3M | -$8.3M | -$8.1M | -$7.7M | -$6.1M | -$7.2M | -$4.7M | -$5.3M | -$6.0M | -$2.8M |
| Selling And Marketing Expense | $15.2M | $16.9M | $16.6M | $16.5M | $16.7M | $17.5M | $14.5M | $14.6M | $13.5M | $11.2M | $11.1M | $9.4M | $6.9M | $7.5M | $6.3M | $6.3M | $4.1M | $5.3M | $4.7M | $3.9M | $4.0M | $3.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $20.7M | $20.2M | $18.5M | $19.0M | $16.1M | $16.6M | $15.1M | $14.5M | $11.9M | $11.2M | $10.4M | $8.2M | $7.7M | $7.6M | $5.9M | $5.3M | $3.5M | $3.7M | $4.0M | $3.3M | $3.3M | $2.2M |
| Research And Development Expense | $2.3M | $2.2M | $2.5M | $2.1M | $2.3M | $2.4M | $2.4M | $2.5M | $2.1M | $2.1M | $2.1M | $2.0M | $1.4M | $1.9M | $1.7M | $1.2M | $979.0K | $912.0K | $516.0K | $1.1M | $1.7M | $1.0M |
| Other Nonoperating Income Expense | $152.0K | $379.0K | $479.0K | $337.0K | $301.0K | $497.0K | $558.0K | $870.0K | $473.0K | -$195.0K | -$342.0K | -$107.0K | -$127.0K | -$80.0K | $22.0K | $58.0K | -$31.0K | $158.0K | $55.0K | $27.0K | -$786.0K | -$282.0K |
| Operating Income Loss | -$7.6M | -$9.1M | -$10.5M | -$9.4M | -$11.6M | -$4.8M | -$10.2M | -$10.4M | -$11.3M | -$9.5M | -$10.2M | -$9.8M | -$7.2M | -$7.3M | -$7.3M | -$6.9M | -$5.2M | -$6.5M | -$3.9M | -$4.3M | -$5.2M | -$2.5M |
| Operating Expenses | $21.5M | $23.2M | $23.0M | $22.2M | $22.6M | $23.7M | $20.6M | $20.6M | $19.2M | $16.8M | $16.8M | $14.8M | $11.8M | $12.4M | $10.7M | $10.2M | $7.3M | $8.7M | $6.5M | $6.2M | $7.0M | $3.9M |
| Gross Profit | $14.0M | $14.1M | $12.5M | $12.9M | $11.1M | $11.3M | $10.4M | $10.2M | $7.9M | $7.3M | $6.6M | $5.0M | $4.6M | $5.1M | $3.5M | $3.3M | $2.1M | $2.2M | $2.6M | $1.9M | $1.8M | $1.4M |
| General And Administrative Expense | $3.9M | $4.1M | $3.8M | $3.7M | $3.6M | $3.8M | $3.7M | $3.5M | $3.6M | $3.5M | $3.6M | $3.5M | $3.5M | $3.0M | $2.8M | $2.6M | $2.1M | $2.5M | $1.2M | $1.2M | $1.3M | $1.4M |
| Comprehensive Income Net Of Tax | -$8.6M | -$9.9M | -$11.3M | -$10.3M | -$12.6M | -$5.7M | -$10.9M | -$10.8M | -$12.1M | -$10.6M | -$12.6M | -$10.8M | -$8.2M | -$8.3M | -$8.1M | -$7.7M | -$6.1M | -$7.2M | -$4.7M | -$5.3M | -$6.0M | -$2.8M |
| Cost Of Goods And Services Sold Amortization | $95.0K | $95.0K | $95.0K | $95.0K | $95.0K | $95.0K | $95.0K | $95.0K | $95.0K | $95.0K | $538.0K | $76.0K | $76.0K | $76.0K | $76.0K | $76.0K | $76.0K | $76.0K | $76.0K | $76.0K | $76.0K | $76.0K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$2.0K | $2.0K | $1.0K | $51.0K | $1.0K | $6.0K | $51.0K | -$36.0K | -$30.0K | $133.0K | $134.0K | $47.0K | $38.0K | $1.0K | -$11.0K | -$29.0K | $4.0K | $27.0K | $1.0K | $1.0K | -$4.0K | |
| Nonoperating Income Expense | -$1.0M | -$809.0K | -$740.0K | -$1.0M | -$1.0M | -$835.0K | -$776.0K | -$428.0K | -$773.0K | -$1.2M | -$2.5M | -$1.0M | -$1.0M | -$944.0K | -$867.0K | -$840.0K | -$915.0K | -$721.0K | -$810.0K | -$961.0K | ||
| Interest Expense | $1.3M | $1.3M | $1.3M | $1.2M | $1.0M | $934.0K | $911.0K | $922.0K | $864.0K | $889.0K | $898.0K | $884.0K | $879.0K | $899.0K | $914.0K | $912.0K | $309.0K | |||||
| Interest Expense Nonoperating | $1.2M | $1.2M | $1.2M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $6.3M | $28.5M | $18.9M | $14.3M | $20.1M | $49.0M | $31.0M | -$137.9M | -$108.2M | -$81.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $51.1M | $52.9M | $47.0M | $42.0M | $43.9M | $74.4M | $45.3M | $17.3M | $11.3M | $1.5M |
| Cash And Cash Equivalents At Carrying Value | $50.8M | $52.7M | $46.7M | $42.0M | $43.9M | $74.4M | $17.3M | |||
| Inventory Write Down | $2.4M | $3.0M | $1.4M | $1.9M | $1.4M | $1.3M | $1.6M | $2.2M | $452.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.8M | $5.9M | $5.0M | -$1.9M | -$30.5M | $29.1M | $28.0M | $5.9M | $9.9M | |
| Retained Earnings Accumulated Deficit | -$397.6M | -$358.7M | -$320.9M | -$274.2M | -$229.9M | -$196.7M | -$167.9M | -$137.9M | ||
| Receivables Net Current | $10.3M | $10.1M | $9.7M | $6.6M | $4.2M | $2.7M | $2.8M | $1.3M | ||
| Property Plant And Equipment Net | $2.2M | $2.3M | $2.0M | $1.7M | $1.2M | $626.0K | $677.0K | $758.0K | ||
| Prepaid Expense And Other Assets Current | $3.4M | $2.5M | $2.1M | $2.0M | $3.2M | $2.2M | $2.3M | $330.0K | ||
| Liabilities Current | $18.0M | $15.6M | $17.0M | $12.4M | $10.6M | $6.6M | $6.7M | $9.6M | ||
| Liabilities And Stockholders Equity | $81.4M | $86.6M | $78.0M | $67.9M | $62.5M | $86.5M | $67.9M | $27.2M | ||
| Liabilities | $75.1M | $58.1M | $59.2M | $53.6M | $42.4M | $37.4M | $37.0M | $40.9M | ||
| Inventory Net | $11.0M | $12.8M | $13.2M | $11.8M | $7.7M | $3.9M | $4.6M | $4.3M | ||
| Assets Current | $75.6M | $78.1M | $71.7M | $62.4M | $59.1M | $83.2M | $64.3M | $23.3M | ||
| Assets | $81.4M | $86.6M | $78.0M | $67.9M | $62.5M | $86.5M | $67.9M | $27.2M | ||
| Accounts Payable Current | $2.3M | $2.1M | $1.7M | $1.5M | $2.4M | $652.0K | $3.2M | $3.4M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $91.0K | $90.0K | $91.0K | $150.0K | -$52.0K | -$71.0K | -$19.0K | |||
| Common Stock Value | $44.0K | $39.0K | $24.0K | $19.0K | $15.0K | $14.0K | $11.0K | |||
| Intangible Assets Net Excluding Goodwill | $1.4M | $1.7M | $2.1M | $2.5M | $2.3M | $2.6M | $2.9M | |||
| Other Liabilities Noncurrent | $1.5M | $1.4M | $1.7M | $1.2M | $380.0K | $4.0K | $5.0K | |||
| Accrued Liabilities Current | $15.7M | $13.5M | $15.3M | $10.9M | $8.2M | $5.2M | ||||
| Net Changes In Operating Lease Right Of Use Assets And Liabilities | -$302.0K | $99.0K | $49.0K | $36.0K | ||||||
| Stock Issued During Period Value Vesting Of Common Stock Previously Subject To Repurchase | $1.0K | $3.0K | $4.0K | $5.0K | $31.0K | |||||
| Operating Lease Right Of Use Asset | $1.5M | $1.7M | $2.0M | $1.2M | ||||||
| Long Term Debt Noncurrent | $55.7M | $41.1M | $40.5M | $39.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.6M | $9.2M | $18.1M | -$6.3M | $2.9M | $14.4M | $30.6M | $40.0M | $3.1M | $23.3M | -$1.5M | $10.0M | $27.7M | $35.0M | $41.7M | $56.3M | $63.4M | $24.2M | -$160.4M | -$153.7M | -$145.8M | -$128.5M | -$123.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $30.0M | $35.2M | $43.1M | $17.6M | $26.8M | $37.4M | $58.2M | $65.3M | $30.1M | $54.2M | $27.7M | $33.0M | $53.6M | $60.3M | $65.8M | $81.5M | $85.5M | $41.4M | $10.7M | $15.9M | $9.4M | $1.9M | ||
| Cash And Cash Equivalents At Carrying Value | $29.7M | $35.0M | $42.8M | $17.3M | $26.5M | $37.1M | $58.2M | $65.3M | $30.1M | $54.2M | $27.7M | $33.0M | $53.6M | $60.3M | $65.8M | $81.5M | $85.5M | $41.4M | $45.3M | $10.7M | ||||
| Inventory Write Down | $630.0K | $560.0K | $576.0K | $845.0K | $582.0K | $405.0K | $739.0K | |||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.8M | -$9.6M | -$11.9M | -$10.9M | -$8.6M | -$3.9M | -$7.8M | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$388.5M | -$379.9M | -$370.0M | -$349.5M | -$339.2M | -$326.6M | -$308.0M | -$297.0M | -$286.3M | -$264.2M | -$253.5M | -$240.8M | -$221.3M | -$213.0M | -$204.8M | -$188.9M | -$181.2M | -$175.1M | -$160.4M | |||||
| Receivables Net Current | $11.3M | $11.2M | $10.6M | $11.2M | $9.1M | $10.0M | $8.1M | $7.9M | $6.7M | $5.7M | $5.3M | $4.3M | $3.6M | $3.5M | $2.8M | $2.6M | $2.6M | $2.0M | $2.3M | |||||
| Property Plant And Equipment Net | $2.2M | $2.2M | $2.2M | $2.4M | $2.3M | $2.3M | $1.7M | $1.8M | $1.7M | $1.7M | $1.7M | $1.5M | $891.0K | $609.0K | $584.0K | $652.0K | $678.0K | $693.0K | $716.0K | |||||
| Prepaid Expense And Other Assets Current | $3.5M | $3.2M | $2.8M | $2.0M | $2.1M | $1.9M | $1.7M | $1.9M | $1.6M | $1.9M | $2.3M | $2.7M | $2.1M | $2.4M | $1.9M | $867.0K | $1.5M | $1.8M | $365.0K | |||||
| Liabilities Current | $17.0M | $19.1M | $16.5M | $16.9M | $15.0M | $15.2M | $15.3M | $13.0M | $14.4M | $15.2M | $11.9M | $12.3M | $9.4M | $7.3M | $5.6M | $5.3M | $3.6M | $4.2M | $6.3M | |||||
| Liabilities And Stockholders Equity | $61.6M | $67.5M | $77.3M | $53.0M | $60.2M | $71.8M | $87.3M | $94.4M | $58.8M | $79.6M | $51.3M | $55.4M | $68.8M | $73.8M | $78.3M | $92.4M | $97.6M | $58.8M | $23.1M | |||||
| Liabilities | $60.0M | $58.4M | $59.1M | $59.3M | $57.3M | $57.5M | $56.8M | $54.4M | $55.6M | $56.3M | $52.9M | $45.3M | $41.1M | $38.8M | $36.6M | $36.0M | $34.1M | $34.6M | $38.1M | |||||
| Inventory Net | $11.6M | $11.4M | $13.5M | $13.6M | $13.4M | $13.6M | $14.3M | $14.1M | $15.1M | $12.1M | $10.3M | $10.3M | $6.3M | $4.5M | $4.7M | $4.0M | $4.6M | $4.8M | $4.3M | |||||
| Assets Current | $56.0M | $60.7M | $69.7M | $44.1M | $51.1M | $62.6M | $82.3M | $89.2M | $53.5M | $74.0M | $45.6M | $50.3M | $65.5M | $70.7M | $75.2M | $89.0M | $94.1M | $55.3M | $17.6M | |||||
| Assets | $61.6M | $67.5M | $77.3M | $53.0M | $60.2M | $71.8M | $87.3M | $94.4M | $58.8M | $79.6M | $51.3M | $55.4M | $68.8M | $73.8M | $78.3M | $92.4M | $97.6M | $58.8M | $23.1M | |||||
| Accounts Payable Current | $2.4M | $1.7M | $4.0M | $2.5M | $2.3M | $3.4M | $3.1M | $2.3M | $5.2M | $4.9M | $2.2M | $5.7M | $2.3M | $1.3M | $965.0K | $976.0K | $948.0K | $1.4M | $1.7M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $91.0K | $93.0K | $91.0K | $149.0K | $98.0K | $97.0K | $135.0K | $84.0K | $120.0K | $262.0K | $129.0K | -$5.0K | -$43.0K | -$81.0K | -$82.0K | -$17.0K | $12.0K | $8.0K | -$2.0K | |||||
| Common Stock Value | $40.0K | $40.0K | $40.0K | $25.0K | $25.0K | $25.0K | $24.0K | $24.0K | $19.0K | $19.0K | $15.0K | $15.0K | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | $11.0K | ||||||
| Intangible Assets Net Excluding Goodwill | $1.5M | $1.5M | $1.6M | $1.8M | $1.9M | $2.0M | $2.2M | $2.3M | $2.4M | $2.6M | $2.7M | $2.2M | $2.4M | $2.5M | $2.5M | $2.7M | $2.8M | $2.8M | ||||||
| Other Liabilities Noncurrent | $1.6M | $1.2M | $1.3M | $1.5M | $1.5M | $1.6M | $1.1M | $1.1M | $1.2M | $1.3M | $1.3M | $1.4M | $388.0K | $395.0K | $8.0K | $1.0K | $5.0K | |||||||
| Accrued Liabilities Current | $14.6M | $14.0M | $12.5M | $14.4M | $12.7M | $11.8M | $12.2M | $10.8M | $9.2M | $10.4M | $2.8M | $3.5M | $3.6M | |||||||||||
| Net Changes In Operating Lease Right Of Use Assets And Liabilities | $26.0K | $22.0K | $10.0K | $8.0K | ||||||||||||||||||||
| Stock Issued During Period Value Vesting Of Common Stock Previously Subject To Repurchase | $1.0K | $1.0K | $2.0K | $3.0K | $1.0K | |||||||||||||||||||
| Operating Lease Right Of Use Asset | $1.6M | $1.6M | $1.7M | $1.8M | $1.9M | $1.9M | $1.1M | $1.1M | $1.2M | $1.3M | $1.3M | $1.3M | ||||||||||||
| Long Term Debt Noncurrent | $41.5M | $38.1M | $41.3M | $41.0M | $40.8M | $40.7M | $40.4M | $40.2M | $40.1M | $39.8M | $39.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | $25.6M | $22.4M | $18.0M | $13.6M | $10.3M | $6.7M | $5.9M | $4.5M | $1.7M |
| Share Based Compensation | $3.8M | $4.4M | $5.0M | $4.0M | $3.7M | $2.1M | $457.0K | $216.0K | $197.0K |
| Proceeds From Stock Options Exercised | $1.0K | $226.0K | $127.0K | $19.0K | $547.0K | $175.0K | $14.0K | $5.0K | $2.0K |
| Payments To Acquire Property Plant And Equipment | $448.0K | $989.0K | $611.0K | $872.0K | $627.0K | $167.0K | $197.0K | $62.0K | $114.0K |
| Net Cash Provided By Used In Operating Activities | -$28.2M | -$41.6M | -$40.9M | -$40.7M | -$30.4M | -$24.5M | -$25.5M | -$19.9M | -$16.4M |
| Net Cash Provided By Used In Investing Activities | $846.0K | $4.5M | -$599.0K | -$1.9M | -$627.0K | $9.1M | -$12.0M | -$1.6M | -$101.0K |
| Net Cash Provided By Used In Financing Activities | $25.8M | $43.1M | $46.3M | $40.9M | $585.0K | $44.4M | $65.5M | $27.4M | $26.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$133.0K | -$227.0K | $81.0K | -$1.2M | $992.0K | -$66.0K | $2.0M | -$99.0K | $58.0K |
| Increase Decrease In Inventories | $503.0K | $3.0M | $2.7M | $6.1M | $5.2M | $620.0K | $1.8M | $4.8M | $127.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $1.8M | -$1.8M | $4.2M | $2.4M | $2.7M | $2.3M | -$118.0K | -$1.2M | $1.6M |
| Increase Decrease In Accounts Receivable | $110.0K | $762.0K | $3.1M | $2.4M | $1.6M | -$149.0K | $1.5M | $541.0K | $578.0K |
| Increase Decrease In Accounts Payable | $141.0K | $482.0K | $11.0K | -$884.0K | $1.6M | -$2.0M | -$773.0K | $1.9M | -$748.0K |
| Adjustments Related To Tax Withholding For Share Based Compensation | $205.0K | $369.0K | $289.0K | $157.0K | |||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$217.0K | $28.0K | $164.0K | -$144.0K | $11.0K | $17.0K | -$4.0K | ||
| Payments Related To Tax Withholding For Share Based Compensation | $205.0K | $369.0K | $289.0K | $157.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | $6.6M | $6.0M | $5.9M | $6.0M | $4.9M | $5.2M | $4.6M | $4.2M | $3.9M | $3.7M | $3.3M | $3.2M | $3.0M | $2.4M | $2.3M | $2.0M | $1.3M | $1.5M | $1.3M | $1.3M | $1.4M | $769.0K |
| Share Based Compensation | $1.0M | $1.1M | $1.1M | $901.0K | $694.0K | $449.0K | $60.0K | |||||||||||||||
| Proceeds From Stock Options Exercised | $1.0K | $220.0K | $44.0K | $7.0K | $36.0K | $8.0K | $3.0K | |||||||||||||||
| Payments To Acquire Property Plant And Equipment | $32.0K | $304.0K | $115.0K | $336.0K | $22.0K | $68.0K | $48.0K | |||||||||||||||
| Net Cash Provided By Used In Operating Activities | -$9.7M | -$14.4M | -$11.6M | -$10.4M | -$8.6M | -$7.3M | -$7.8M | |||||||||||||||
| Net Cash Provided By Used In Investing Activities | $138.0K | $4.7M | -$115.0K | -$336.0K | -$22.0K | $3.9M | -$548.0K | |||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$116.0K | $56.0K | -$235.0K | -$146.0K | $36.0K | -$514.0K | $484.0K | |||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$180.0K | -$479.0K | -$398.0K | -$497.0K | -$349.0K | -$544.0K | -$41.0K | |||||||||||||||
| Increase Decrease In Inventories | $1.3M | $1.4M | $3.9M | $3.5M | $1.4M | $617.0K | $802.0K | |||||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$930.0K | -$3.5M | -$1.7M | -$1.9M | -$1.2M | -$692.0K | -$554.0K | |||||||||||||||
| Increase Decrease In Accounts Receivable | $402.0K | $234.0K | $18.0K | $85.0K | $112.0K | -$781.0K | $579.0K | |||||||||||||||
| Increase Decrease In Accounts Payable | $1.9M | $1.5M | $3.7M | $3.3M | $312.0K | -$1.3M | -$945.0K | |||||||||||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $21.0K | $3.0K | $177.0K | $19.0K | $11.0K | $328.0K | $5.0K | $1.0K | $279.0K | $4.0K | $153.0K | |||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$134.0K | $46.0K | $29.0K | -$3.0K | $6.0K | |||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $177.0K | $328.0K | $279.0K | $153.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.83 | -$1.33 | -$2.04 | -$2.72 | -$2.30 | -$2.23 | -$17.10 | -$101.41 | |
| Weighted Average Number Of Shares Outstanding Basic | 46.9M | 28.5M | 22.9M | 16.3M | 14.5M | 12.9M | 1.8M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 46.9M | 28.5M | 22.9M | 16.3M | 14.5M | 12.9M | 1.8M | ||
| Earnings Per Share Basic | $-0.83 | $-1.33 | $-2.04 | $-2.72 | $-2.30 | $-2.23 | $-17.10 | ||
| Common Stock Shares Outstanding | 44.5M | 39.4M | 24.5M | 19.2M | 14.5M | 14.4M | 11.4M | 295.7K | |
| Common Stock Shares Issued | 44.5M | 39.4M | 24.5M | 19.2M | 14.5M | 14.4M | 11.4M | 296.6K | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 12.9M | 1.8M | 295.0K | 292.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.19 | -$0.22 | -$0.25 | -$0.42 | -$0.51 | -$0.23 | -$0.45 | -$0.46 | -$0.63 | -$0.64 | -$0.88 | -$0.75 | -$0.57 | -$0.57 | -$0.56 | -$0.53 | -$0.53 | -$0.63 | -$22.58 | -$27.06 | ||
| Weighted Average Number Of Shares Outstanding Basic | 45.4M | 45.4M | 45.3M | 24.7M | 24.7M | 24.6M | 24.5M | 23.2M | 19.2M | 16.8M | 14.6M | 14.5M | 14.5M | 14.5M | 14.4M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 45.4M | 45.4M | 45.3M | 24.7M | 24.7M | 24.6M | 24.5M | 23.2M | 19.2M | 16.8M | 14.6M | 14.5M | 14.5M | 14.5M | 14.4M | |||||||
| Earnings Per Share Basic | $-0.19 | $-0.22 | $-0.25 | $-0.42 | $-0.51 | $-0.23 | $-0.45 | $-0.46 | $-0.63 | $-0.64 | $-0.88 | $-0.75 | $-0.57 | $-0.57 | $-0.56 | |||||||
| Common Stock Shares Outstanding | 40.3M | 39.6M | 39.6M | 24.7M | 24.7M | 24.7M | 24.5M | 24.5M | 19.2M | 19.2M | 14.6M | 14.6M | 14.5M | 14.5M | 14.4M | 14.4M | 14.4M | 11.4M | 298.1K | |||
| Common Stock Shares Issued | 40.3M | 39.6M | 39.6M | 24.7M | 24.7M | 24.7M | 24.5M | 24.5M | 19.2M | 19.2M | 14.6M | 14.6M | 14.5M | 14.5M | 14.4M | 14.4M | 14.4M | 11.4M | 299.0K | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 127.2M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 14.5M | 14.5M | 14.4M | 14.4M | 11.4M | 11.4M | 297.8K | 296.5K | 296.0K | 295.2K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.8M | $4.4M | $5.0M | $4.0M | $3.7M | $2.0M | $457.0K | $216.0K | $197.0K |
| Stock Issued During Period Value Stock Options Exercised | $127.0K | $19.0K | $547.0K | $175.0K | $14.0K | $5.0K | $2.0K | ||
| Paid In Kind Interest | $529.0K | $609.0K | $599.0K | $657.0K | $664.0K | $584.0K | $523.0K | $712.0K | $2.1M |
| Interest Paid Net | $4.7M | $4.1M | $4.6M | $3.4M | $2.9M | $3.0M | $3.1M | $1.1M | $329.0K |
| Depreciation | $630.0K | $632.0K | $428.0K | $383.0K | $231.0K | $221.0K | $278.0K | $463.0K | $761.0K |
| Foreign Currency Transaction Gain Loss Before Tax | -$76.0K | $35.0K | $316.0K | -$420.0K | -$12.0K | $70.0K | $21.0K | ||
| Additional Paid In Capital | $403.7M | $387.1M | $339.7M | $288.4M | $250.1M | $245.7M | $198.8M | ||
| Capital Expenditures Incurred But Not Yet Paid | $66.0K | $119.0K | $7.0K | $166.0K | $3.0K | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $105.0K | $281.0K | $88.0K | $50.0K | $38.0K | $34.0K | |||
| Stock Issued During Period Value New Issues | $46.3M | $34.4M | $82.0K | $44.7M | $50.6M | ||||
| Stock Issued During Period Shares Stock Options Exercised | 25.4K | 3.6K | 77.2K | 27.8K | 2.5K | 1.4K | 404.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $955.0K | $985.0K | $1.0M | $1.1M | $1.1M | $1.1M | $1.4M | $1.3M | $1.1M | $1.0M | $1.0M | $901.0K | $733.0K | $1.4M | $694.0K | $543.0K | $494.0K | $449.0K | $64.0K | $59.0K | $60.0K | $61.0K |
| Stock Issued During Period Value Stock Options Exercised | $6.0K | $1.0K | $56.0K | $44.0K | $1.0K | $5.0K | $7.0K | $259.0K | $116.0K | $36.0K | $119.0K | $36.0K | $8.0K | $4.0K | $5.0K | $3.0K | $1.0K | |||||
| Paid In Kind Interest | $151.0K | $151.0K | $147.0K | $178.0K | $156.0K | $134.0K | $119.0K | |||||||||||||||
| Interest Paid Net | $1.4M | $1.2M | $1.1M | $733.0K | $733.0K | $745.0K | $793.0K | |||||||||||||||
| Depreciation | $172.0K | $139.0K | $120.0K | $78.0K | $64.0K | $56.0K | $70.0K | |||||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$66.0K | $24.0K | $94.0K | -$101.0K | $17.0K | -$38.0K | ||||||||||||||||
| Additional Paid In Capital | $389.9M | $389.0M | $388.0M | $343.1M | $341.9M | $340.8M | $338.4M | $336.9M | $289.3M | $287.3M | $251.8M | $250.8M | $249.1M | $248.1M | $246.5M | $245.2M | $244.5M | $199.3M | ||||
| Capital Expenditures Incurred But Not Yet Paid | $176.0K | $18.0K | $16.0K | $4.0K | ||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $45.0K | $60.0K | $117.0K | $164.0K | $88.0K | |||||||||||||||||
| Stock Issued During Period Value New Issues | $46.3M | $34.4M | $44.7M | |||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 9.9K | 1.2K | 3.1K | 1.3K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.